Tuesday, 21 November 2017

Blood Glucose Monitoring Devices Market 2022 Research Report: Overview, Consumption and New Feasibility Analysis

Global blood glucose monitoring devices market is expected to have a gaining popularity over the forecast period. The factors driving the market are increasing prevalence of diabetes, rise in geriatric population and, high awareness levels among healthcare professionals and patients. Introduction of technological advanced devices with increased speed efficiency and specificity are also estimated to boost the market over the decade. According to American Diabetes Association, in 2014, the rate of diabetes in U.S, tended to be highest among the people aged 65 years or older around 25.9% while in youth, it is around 0.25% in 20800 young people. The rate can increase to around 4.4% over the forecast period.


The blood glucose monitoring devices market is segmented on the basis of type of product which include blood glucose meter, blood glucose testing strips and Lancets. Blood glucose meter determines the imprecise concentration of blood glucose level. It is further segmented into traditional glucose meters and continuous glucose meters (assess blood glucose levels on a continuous basis). The efficiency and accuracy of the blood glucose monitoring devices and availability of them at nominal cost supports the market growth. Blood glucose testing strip type is one of the major segment among all the devices due to the affordable price, easy to use and easy availability in the market. In addition, the growing use of strips in institutions and home boost the sales of the device.

Geographically, the blood glucose monitoring devices market is segmented in North America, Europe, Asia Pacific and rest of the world. North America is expected to hold one of the largest market share owing to higher number of diabetic patients, increase in geriatric population, rise in healthcare expenditure, high healthcare infrastructure and active reimbursement policies. According to CDC data, 9.3% of the U.S population have diabetes, out of which 27.8% of diabetic people are undiagnosed.

Asia Pacific blood glucose monitoring devices market is estimated to have a lucrative growth over the forecast period. The rise in overall population growth, high disposable income and upcoming government initiatives are the factors supporting the market growth of the region.The key players of blood glucose monitoring devices market are Roche Diagnostics, Bayer Healthcare Division, Johnson & Johnson, Nipro Diagnostics, Medtronic Inc., Dexcom LifeScan, Abbott Laboratories, Home Diagnostics Inc., Arkray and AgaMatrix.


No comments:

Post a Comment